Training course on Quality Assurance and Total Quality Management

As a joint venture between LACDR and the Institute for

Biotechnology Studies Delft/Leiden, the Graduate School

for Food Technology, Agrobiotechnology, Nutrition and

Health Services in Wageningen, a training course an

Quality Assurance and Total Quality Management has

been developed. The programme will comprise of six

modules of 2±5 days:

1 Towards total quality management: design and imple-

mentation of quality assurance systems;

2 Pharmaceutical microbiology and validation;

3 Quality management in analytical laboratories;

4 From idea to registration: good practices in research,

development and production of pharmaceutical products;

5 Biological production from genetics to downstream

processing;

6 Food technology and food safety.

Certi®cates/Diploma

After attending a module, the participants will receive a

certi®cate for attendance. In addition, the participants are

offered the possibility to complete the course through an

examination covering the pharma/biotech program

(module 1, 2, 3, 4 and 5) or covering the food/biotech

program (module 1, 2, 3, 5 and 6). An additional

examination fee will be charged

The course is aimed at individuals employed in industry

(or planning an industrial career) who wish to supplement

their academic curriculum with subjects relevant to quality

control, quality assurance and total quality management.

The ®rst module will be given in April 2000.

For further details contact:

Dr van der Meer-Lerk, Biotechnology Studies Delft

Leiden (BODL). Kluyver Laboratory, Julianalaan 67,

2628 BC Delft, The Netherlands, Tel.:+ 31 15 2781922,

Fax:+ 31 15 2782355. E-mail: bodl@stm.tudelft.ni,

http://www.kluyver.stm.tudelft nL/bodif.htm

University: Leiden University

Organization: Leiden/Amsterdam Center for Drug

Research, Godaeus Laboratories

Address: Einsteinweg 55/PO Box 9502 230ORA,

Leiden, The Netheriands

Tel.:+ 31 71 1274341

Fax.:+ 31 71 5274277

Announcements

290 f 2000 Blackwell Science Ltd Br J Clin Pharmacol, 49, 289±290